The US Supreme Court has allowed the Trump administration to temporarily halt hundreds of millions in medical research grants, raising concerns over the impact on diversity and inclusion initiatives.
In a contentious ruling, the Supreme Court has allowed the Trump administration to slash nearly $800 million in NIH grants aimed at studying diseases affecting minority, gay, and transgender communities, amidst ongoing legal disputes.
In a landmark decision, a Boston federal judge declared the Trump administration's termination of NIH diversity-related grants illegal, citing racial discrimination and restoring over $1 billion in funding. This ruling could reshape future funding for minority and LGBTQ research.
Trump administration's actions blocking NIH grant approvals lead to uncertainty for researchers focusing on diseases like Lyme, heart, and lung diseases. The delay in publishing grant meeting notices creates hurdles for vital health research funding.
